Abstract
| Language | English |
|---|---|
| Pages | S96-S96 |
| Number of pages | 1 |
| Journal | The Lancet |
| Volume | 381 |
| Issue number | Supplement 2 |
| DOIs | |
| Publication status | Published - 17 Jun 2013 |
Fingerprint
Keywords
- cost-effectiveness
- health interventions
Cite this
}
An agent-based simulation modelling approach to extended cost-effectiveness analysis of health interventions. / Nandi, Arindam; Megiddo, Itamar; Prabhakaran, Dorairaj; Laxminarayan, Ramanan.
In: The Lancet, Vol. 381, No. Supplement 2, 17.06.2013, p. S96-S96.Research output: Contribution to journal › Article
TY - JOUR
T1 - An agent-based simulation modelling approach to extended cost-effectiveness analysis of health interventions
AU - Nandi, Arindam
AU - Megiddo, Itamar
AU - Prabhakaran, Dorairaj
AU - Laxminarayan, Ramanan
PY - 2013/6/17
Y1 - 2013/6/17
N2 - Cost-effectiveness analysis (CEA) is widely used as a tool for prioritising health interventions, particularly in low-income and middle-income settings. However, among the major limitations of CEA are the omission of health-care seeking behaviour, heterogeneous mechanisms across populations or regions that determine the delivery and quality of health interventions, and the economic benefits of such interventions. Extended CEA complements basic CEA and provides a basis for a multicriteria decision-making approach that looks beyond health measures, but is far less complex than a benefit–cost analysis.
AB - Cost-effectiveness analysis (CEA) is widely used as a tool for prioritising health interventions, particularly in low-income and middle-income settings. However, among the major limitations of CEA are the omission of health-care seeking behaviour, heterogeneous mechanisms across populations or regions that determine the delivery and quality of health interventions, and the economic benefits of such interventions. Extended CEA complements basic CEA and provides a basis for a multicriteria decision-making approach that looks beyond health measures, but is far less complex than a benefit–cost analysis.
KW - cost-effectiveness
KW - health interventions
U2 - 10.1016/S0140-6736(13)61350-1
DO - 10.1016/S0140-6736(13)61350-1
M3 - Article
VL - 381
SP - S96-S96
JO - Lancet
T2 - Lancet
JF - Lancet
SN - 0140-6736
IS - Supplement 2
ER -